Bill Text: IN Senate Bill 72 – 2012 Regular Session | eLobbyist.
It was fairly easy to get Indiana Senate bill 72 passed by the republicans with most of the meat hacked out of it. What’s left is a bill that stops telemed abortions. It requires certain info to be given to women before giving the drugs, but it does not require that the info on the safety of the drugs be accurate.
Abortionists do not have to report treatment failures or adverse events, deaths, hospitalizations, caused by use of the abortion drugs. Therefore the safety of the drugs can never be assessed or compared with that of childbirth.
The definition of abortion drug, which is the main thing left in the bill can be construed include Ella, (ulipristal acetate) when the doses are accumulated in sufficient quantity to induce a home abortion.
There is no longer a visible requirement that the abortion drugs be used according to the FDA approved label. Therefore planned unparenthood can continue its practice of using one third the recommended dose of mifepristone, double the dose of misoprostil, and ejecting the embryo or fetus dead or alive.
The top link will lead you to what’s left of the bill as it leaves the senate.
Pharmacists will require special definitions of interceptive drugs, (which kill the early human embryo by stopping implantation), and and entirely separate legislation to be excused from dispensing the morning after pills, including Ella, which can be used for home abortions if the doses are accumulated.
Indiana panel backs abortion pill limit | The Courier-Journal | courier-journal.com.
Dr. John Stutzman, medical director of Planned Parenthood of Indiana, (and apparently allowed to teach at Indiana University), is not happy with the passage of Senate Bill 72 through the Health Committee. He says that using 200mg of mifepristone for chemical abortion, instead of the FDA recommended 600mg dose is sufficient. Apparently their purpose of reducing the progesterone receptor blocker and increasing the drug that causes violent uterine contractions is to avoid “side effects”. Planned parenthood sends the woman home with double the recommended dose of misoprostil to expel the embryo or fetus dead or alive.
No one is counting the failures which end up at our hospitals to have the abortion job finished up, and mind you, planned parenthood is NOT interested in having to report said failures so they can be tabulated and evaluated. (That requirement had already been removed from the bill.)
Whether the abortion job is finished by the chemical method or by follow up at a hospital (transferring liability to the hospital, and expense to that institution or to us) it is deemed a success at planned parenthood.
More commentary from Catholic News out of Ft. Wayne.
Since the time Pharmer was first informed of current Indiana legislation to regulate the use of abortion drugs, there have been significant changes to the bill.
Of special concern is that no longer a requirement to report adverse events associated with abortion drug use.
Existing forms and services can be used for such reporting with respect to drugs and medical devices, for example:
Adverse events associated with or related to childbirth are reportable as such to include the whole period of pregnancy, childbirth and the year after delivery, at the recommendation of the ACOG.
The non reporting of abortion related adverse events and deaths, combined with the more readily reported pregnancy related or associated deaths has led to false statistics comparing the relative risk of childbirth and abortion.
Senate Bill 72 is now structured in such a way as to facilitate a means to convince women that abortion is safer than childbirth. The lack of requirement for reporting abortion drug adverse events serves to worsen the current skewing and misrepresentation of facts, which denies patients the opportunity of giving informed consent.
Useful parts of the bill worth noting: The definition of abortion inducing drug includes “off-label use of drugs known to have abortion inducing properties if the drug is prescribed with the intent of causing an abortion”. (Ch.3 sec.1a)
The bill also requires that the abortionist “follows the drug label protocol for the abortion producing drug. (Ch3. sec 3a-2)
Expect a firestorm from planned parenthood which utilizes mifepristone, RU-486, in an off label manner by using less of the drug (a single 200mg tab) than recommended on the label, (three 200mg tablets) and by using it up to, or at 63 days gestation instead of 49 days.
According to the Mifeprex label, U.S., three x 200mg tabs are to be administered in a single dose, and the patient returns to the clinic in 2 days to take 2 tabs (400mcg) of misoprostil, to expel the human embryo or fetus. Planned Parenthood of Indiana is sending the patients home with four tablets (800mcg) according to their own info.
From Drs Gary and Harrison at Medscape: “The US clinical trial demonstrated a failure rate of 8% at 49 days or less from the last menstrual period (LMP), increasing to 17% at 50-56 days from the LMP, and further increasing to a 23% failure at 57-63 days from the LMP, as established by sonographic criteria………One serious concern raised by this review of AERs is the suggested fetal malformation rate of at least 23% following mifepristone failures that resulted in continuation of a live pregnancy.”
Annals of Pharmacotherapy analysis of mifepristone adverse events reported to FDA 2000-2004.